Affordable Access

A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.

Authors
  • Lee, J S
  • Komaki, R
  • Fossella, F V
  • Glisson, B S
  • Hong, W K
  • Cox, J D
Type
Published Article
Journal
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier
Publication Date
Oct 01, 1998
Volume
42
Issue
3
Pages
479–486
Identifiers
PMID: 9806504
Source
Medline
License
Unknown

Abstract

This long-term survival outcome compares favorably with that of other chemoradiation therapy trials and even with those reported in multimodality trials including surgery. These results suggest that intensive concurrent chemoradiation therapy is feasible, and some patients with locally advanced inoperable NSCLC may enjoy long-term survivorship following nonsurgical therapy.

Report this publication

Statistics

Seen <100 times